This article appeared in Fierce Biotech, March 2 2022 See the article in full here
March 2, 2022 - Articles
March 2, 2022 - Articles
This article appeared in Fierce Biotech, March 2 2022 See the article in full here
March 2, 2022 - Articles
Epsilogen Ltd was profiled in BioWorld on March 2, 2022. See the article in full here
April 14, 2021 - Articles
This article first appeared in Drug Discovery World, Spring 2021, Volume 22, Issue 2. See the article in full here
June 5, 2020 - Articles
Epsilogen: co-opting IgE antibodies against cancer Epsilogen Ltd was profiled in BioCentury’s Emerging Company Profile on June 5, 2020. See the article in full here
June 18, 2018 - Articles
Emerging Company Profile: IGEM Therapeutics has been spun out of King’s College London to evaluate the use of IgE-based monoclonal antibodies for the treatment of cancer, including difficult-to-reach solid tumors…. ….. See the...
June 18, 2018 - Articles
Not to be Sneezed At One of the stand-out technologies discussed by London-based immuno-oncology start-up Epsilogen was in antibody therapeutics….. See the article in full here: ...